 | • レポートコード：QYR9NV13808 • 出版社/出版日：QYResearch / 2019年11月16日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・ヘルスケア |
| Single User | ￥518,000 (USD3,500) | ▷ お問い合わせ |
| Enterprise License | ￥1,036,000 (USD7,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートは、潰瘍性大腸炎免疫薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、アダリムマブ、セルトリズマブペゴル、トファシチニブ、エタネルセプト、ゴリムマブ、アバタセプト、インフリキシマブ、その他に、用途別には、関節リウマチ、クローン病(CD)、強直性脊椎炎(AS)、乾癬(Ps)、潰瘍性大腸炎(UC)にセグメント区分し、潰瘍性大腸炎免疫薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・潰瘍性大腸炎免疫薬の世界市場概要 ・潰瘍性大腸炎免疫薬の製造コスト構成分析 ・潰瘍性大腸炎免疫薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・潰瘍性大腸炎免疫薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・潰瘍性大腸炎免疫薬のセグメント分析（種類別） （アダリムマブ、セルトリズマブペゴル、トファシチニブ、エタネルセプト、ゴリムマブ、アバタセプト、インフリキシマブ、その他） ・潰瘍性大腸炎免疫薬のセグメント分析（用途別） （関節リウマチ、クローン病(CD)、強直性脊椎炎(AS)、乾癬(Ps)、潰瘍性大腸炎(UC)） ・潰瘍性大腸炎免疫薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績） （Janssen Biotech, Inc.、Bristol-Myers Squibb Company、AbbVie Inc.、UCBCares、AMGEN、Celltrion Healthcare、Biogen、Genentech USA, Inc.、ROCHE、Pfizer Inc.、） ・潰瘍性大腸炎免疫薬の市場規模予測（2019年～2025年） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・マーケティングチャネル・流通業者・顧客 ・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子） ... |
The global Ulcerative Colitis Immunology Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Ulcerative Colitis Immunology Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Ulcerative Colitis Immunology Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Ulcerative Colitis Immunology Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Ulcerative Colitis Immunology Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Janssen Biotech, Inc.
Bristol-Myers Squibb Company
AbbVie Inc.
UCBCares
AMGEN
Celltrion Healthcare
Biogen
Genentech USA, Inc.
ROCHE
Pfizer Inc.
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Adalimumab
Certolizumab Pegol
Tofacitinib
Etanercept
Golimumab
Abatacept
Infliximab
Others
Segment by Application
Rheumatoid Arthritis
Crohn’s Disease(CD)
Ankylosing Spondylitis(AS)
Psoriasis(Ps)
Ulcerative Colitis(UC)
Table of Contents
Executive Summary
1 Industry Overview of Ulcerative Colitis Immunology Drugs
1.1 Definition of Ulcerative Colitis Immunology Drugs
1.2 Ulcerative Colitis Immunology Drugs Segment by Type
1.2.1 Global Ulcerative Colitis Immunology Drugs Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Adalimumab
1.2.3 Certolizumab Pegol
1.2.4 Tofacitinib
1.2.5 Etanercept
1.2.6 Golimumab
1.2.7 Abatacept
1.2.8 Infliximab
1.2.9 Others
1.3 Ulcerative Colitis Immunology Drugs Segment by Applications
1.3.1 Global Ulcerative Colitis Immunology Drugs Consumption Comparison by Applications (2014-2025)
1.3.2 Rheumatoid Arthritis
1.3.3 Crohn’s Disease(CD)
1.3.4 Ankylosing Spondylitis(AS)
1.3.5 Psoriasis(Ps)
1.3.6 Ulcerative Colitis(UC)
1.4 Global Ulcerative Colitis Immunology Drugs Overall Market
1.4.1 Global Ulcerative Colitis Immunology Drugs Revenue (2014-2025)
1.4.2 Global Ulcerative Colitis Immunology Drugs Production (2014-2025)
1.4.3 North America Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
1.4.4 Europe Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
1.4.5 China Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
1.4.6 Japan Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
1.4.7 Southeast Asia Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
1.4.8 India Ulcerative Colitis Immunology Drugs Status and Prospect (2014-2025)
2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Ulcerative Colitis Immunology Drugs
2.3 Manufacturing Process Analysis of Ulcerative Colitis Immunology Drugs
2.4 Industry Chain Structure of Ulcerative Colitis Immunology Drugs
3 Development and Manufacturing Plants Analysis of Ulcerative Colitis Immunology Drugs
3.1 Capacity and Commercial Production Date
3.2 Global Ulcerative Colitis Immunology Drugs Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Ulcerative Colitis Immunology Drugs
3.4 Recent Development and Expansion Plans
4 Key Figures of Major Manufacturers
4.1 Ulcerative Colitis Immunology Drugs Production and Capacity Analysis
4.2 Ulcerative Colitis Immunology Drugs Revenue Analysis
4.3 Ulcerative Colitis Immunology Drugs Price Analysis
4.4 Market Concentration Degree
5 Ulcerative Colitis Immunology Drugs Regional Market Analysis
5.1 Ulcerative Colitis Immunology Drugs Production by Regions
5.1.1 Global Ulcerative Colitis Immunology Drugs Production by Regions
5.1.2 Global Ulcerative Colitis Immunology Drugs Revenue by Regions
5.2 Ulcerative Colitis Immunology Drugs Consumption by Regions
5.3 North America Ulcerative Colitis Immunology Drugs Market Analysis
5.3.1 North America Ulcerative Colitis Immunology Drugs Production
5.3.2 North America Ulcerative Colitis Immunology Drugs Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Ulcerative Colitis Immunology Drugs Import and Export
5.4 Europe Ulcerative Colitis Immunology Drugs Market Analysis
5.4.1 Europe Ulcerative Colitis Immunology Drugs Production
5.4.2 Europe Ulcerative Colitis Immunology Drugs Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Ulcerative Colitis Immunology Drugs Import and Export
5.5 China Ulcerative Colitis Immunology Drugs Market Analysis
5.5.1 China Ulcerative Colitis Immunology Drugs Production
5.5.2 China Ulcerative Colitis Immunology Drugs Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Ulcerative Colitis Immunology Drugs Import and Export
5.6 Japan Ulcerative Colitis Immunology Drugs Market Analysis
5.6.1 Japan Ulcerative Colitis Immunology Drugs Production
5.6.2 Japan Ulcerative Colitis Immunology Drugs Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Ulcerative Colitis Immunology Drugs Import and Export
5.7 Southeast Asia Ulcerative Colitis Immunology Drugs Market Analysis
5.7.1 Southeast Asia Ulcerative Colitis Immunology Drugs Production
5.7.2 Southeast Asia Ulcerative Colitis Immunology Drugs Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Ulcerative Colitis Immunology Drugs Import and Export
5.8 India Ulcerative Colitis Immunology Drugs Market Analysis
5.8.1 India Ulcerative Colitis Immunology Drugs Production
5.8.2 India Ulcerative Colitis Immunology Drugs Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Ulcerative Colitis Immunology Drugs Import and Export
6 Ulcerative Colitis Immunology Drugs Segment Market Analysis (by Type)
6.1 Global Ulcerative Colitis Immunology Drugs Production by Type
6.2 Global Ulcerative Colitis Immunology Drugs Revenue by Type
6.3 Ulcerative Colitis Immunology Drugs Price by Type
7 Ulcerative Colitis Immunology Drugs Segment Market Analysis (by Application)
7.1 Global Ulcerative Colitis Immunology Drugs Consumption by Application
7.2 Global Ulcerative Colitis Immunology Drugs Consumption Market Share by Application (2014-2019)
8 Ulcerative Colitis Immunology Drugs Major Manufacturers Analysis
8.1 Janssen Biotech, Inc.
8.1.1 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.1.2 Janssen Biotech, Inc. Product Introduction, Application and Specification
8.1.3 Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Bristol-Myers Squibb Company
8.2.1 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.2.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
8.2.3 Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 AbbVie Inc.
8.3.1 AbbVie Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.3.2 AbbVie Inc. Product Introduction, Application and Specification
8.3.3 AbbVie Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 UCBCares
8.4.1 UCBCares Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.4.2 UCBCares Product Introduction, Application and Specification
8.4.3 UCBCares Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 AMGEN
8.5.1 AMGEN Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.5.2 AMGEN Product Introduction, Application and Specification
8.5.3 AMGEN Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Celltrion Healthcare
8.6.1 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.6.2 Celltrion Healthcare Product Introduction, Application and Specification
8.6.3 Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Biogen
8.7.1 Biogen Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.7.2 Biogen Product Introduction, Application and Specification
8.7.3 Biogen Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Genentech USA, Inc.
8.8.1 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.8.2 Genentech USA, Inc. Product Introduction, Application and Specification
8.8.3 Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 ROCHE
8.9.1 ROCHE Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.9.2 ROCHE Product Introduction, Application and Specification
8.9.3 ROCHE Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Pfizer Inc.
8.10.1 Pfizer Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
8.10.2 Pfizer Inc. Product Introduction, Application and Specification
8.10.3 Pfizer Inc. Ulcerative Colitis Immunology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
9 Development Trend of Analysis of Ulcerative Colitis Immunology Drugs Market
9.1 Global Ulcerative Colitis Immunology Drugs Market Trend Analysis
9.1.1 Global Ulcerative Colitis Immunology Drugs Market Size (Volume and Value) Forecast 2019-2025
9.2 Ulcerative Colitis Immunology Drugs Regional Market Trend
9.2.1 North America Ulcerative Colitis Immunology Drugs Forecast 2019-2025
9.2.2 Europe Ulcerative Colitis Immunology Drugs Forecast 2019-2025
9.2.3 China Ulcerative Colitis Immunology Drugs Forecast 2019-2025
9.2.4 Japan Ulcerative Colitis Immunology Drugs Forecast 2019-2025
9.2.5 Southeast Asia Ulcerative Colitis Immunology Drugs Forecast 2019-2025
9.2.6 India Ulcerative Colitis Immunology Drugs Forecast 2019-2025
9.3 Ulcerative Colitis Immunology Drugs Market Trend (Product Type)
9.4 Ulcerative Colitis Immunology Drugs Market Trend (Application)
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Ulcerative Colitis Immunology Drugs Customers
11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors
12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer
Figure Picture of Ulcerative Colitis Immunology Drugs
Table Global Ulcerative Colitis Immunology Drugs Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Ulcerative Colitis Immunology Drugs Production Market Share by Types in 2018
Figure Adalimumab Product Picture
Figure Certolizumab Pegol Product Picture
Figure Tofacitinib Product Picture
Figure Etanercept Product Picture
Figure Golimumab Product Picture
Figure Abatacept Product Picture
Figure Infliximab Product Picture
Figure Others Product Picture
Table Global Ulcerative Colitis Immunology Drugs Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Ulcerative Colitis Immunology Drugs Consumption Market Share by Applications in 2018
Figure Rheumatoid Arthritis
Figure Crohn's Disease(CD)
Figure Ankylosing Spondylitis(AS)
Figure Psoriasis(Ps)
Figure Ulcerative Colitis(UC)
Figure Global Ulcerative Colitis Immunology Drugs Revenue (Million USD) (2014-2025)
Figure Global Ulcerative Colitis Immunology Drugs Production (K Pcs) (2014-2025)
Figure North America Ulcerative Colitis Immunology Drugs Market Size (Million USD) (2014-2025)
Figure Europe Ulcerative Colitis Immunology Drugs Market Size (Million USD) (2014-2025)
Figure China Ulcerative Colitis Immunology Drugs Market Size (Million USD) (2014-2025)
Figure Japan Ulcerative Colitis Immunology Drugs Market Size (Million USD) (2014-2025)
Figure Southeast Asia Ulcerative Colitis Immunology Drugs Market Size (Million USD) (2014-2025)
Figure India Ulcerative Colitis Immunology Drugs Market Size (Million USD) (2014-2025)
Table Ulcerative Colitis Immunology Drugs Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Ulcerative Colitis Immunology Drugs in 2018
Figure Manufacturing Process Analysis of Ulcerative Colitis Immunology Drugs
Figure Industry Chain Structure of Ulcerative Colitis Immunology Drugs
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Ulcerative Colitis Immunology Drugs Manufacturing Plants Distribution
Table Ulcerative Colitis Immunology Drugs Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Ulcerative Colitis Immunology Drugs Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Ulcerative Colitis Immunology Drugs Production (K Pcs) of Major Manufacturers (2014-2019)
Table Ulcerative Colitis Immunology Drugs Production Market Share of Major Manufacturers (2014-2019)
Figure Ulcerative Colitis Immunology Drugs Production Share by Manufacturers in 2018
Table Ulcerative Colitis Immunology Drugs Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Ulcerative Colitis Immunology Drugs Revenue Market Share of Major Manufacturers (2014-2019)
Figure Ulcerative Colitis Immunology Drugs Revenue Share by Manufacturers in 2018
Table Ulcerative Colitis Immunology Drugs Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Ulcerative Colitis Immunology Drugs Production by Regions 2014-2019 (K Pcs)
Table Global Ulcerative Colitis Immunology Drugs Production Market Share by Regions 2014-2019
Figure Global Ulcerative Colitis Immunology Drugs Production Market Share by Regions in 2018
Table Global Ulcerative Colitis Immunology Drugs Revenue by Regions 2014-2019 (Million USD)
Table Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Regions 2014-2019
Figure Global Ulcerative Colitis Immunology Drugs Revenue Market Share by Regions in 2018
Table Global Ulcerative Colitis Immunology Drugs Consumption by Regions 2014-2019 (K Pcs)
Table Global Ulcerative Colitis Immunology Drugs Consumption Market Share by Regions 2014-2019
Figure North America Ulcerative Colitis Immunology Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure North America Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table North America Ulcerative Colitis Immunology Drugs Production, Consumption Import and Export (K Pcs)
Figure Europe Ulcerative Colitis Immunology Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Ulcerative Colitis Immunology Drugs Production, Consumption Import and Export (K Pcs)
Figure China Ulcerative Colitis Immunology Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure China Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table China Ulcerative Colitis Immunology Drugs Production, Consumption Import and Export (K Pcs)
Figure Japan Ulcerative Colitis Immunology Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Ulcerative Colitis Immunology Drugs Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Ulcerative Colitis Immunology Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Ulcerative Colitis Immunology Drugs Production, Consumption Import and Export (K Pcs)
Figure India Ulcerative Colitis Immunology Drugs Production Growth Rate 2014-2019 (K Pcs)
Figure India Ulcerative Colitis Immunology Drugs Revenue Growth Rate 2014-2019 (Million USD)
Table India Ulcerative Colitis Immunology Drugs Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Ulcerative Colitis Immunology Drugs Market Share by Application (2014-2019)
Figure Global Value (Consumption) Ulcerative Colitis Immunology Drugs Market Share by Application (2014-2019)
Table Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table Janssen Biotech, Inc. Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table Bristol-Myers Squibb Company Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table AbbVie Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table AbbVie Inc. Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table AbbVie Inc. Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AbbVie Inc. Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table AbbVie Inc. Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure AbbVie Inc. Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table AbbVie Inc. Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table UCBCares Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table UCBCares Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table UCBCares Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table UCBCares Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table UCBCares Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure UCBCares Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table UCBCares Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table AMGEN Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table AMGEN Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table AMGEN Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table AMGEN Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table AMGEN Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure AMGEN Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table AMGEN Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure Celltrion Healthcare Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table Celltrion Healthcare Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table Biogen Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table Biogen Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table Biogen Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biogen Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table Biogen Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure Biogen Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table Biogen Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table Genentech USA, Inc. Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table ROCHE Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table ROCHE Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table ROCHE Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table ROCHE Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table ROCHE Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure ROCHE Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table ROCHE Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Table Pfizer Inc. Ulcerative Colitis Immunology Drugs Production Sites and Area Served
Table Pfizer Inc. Ulcerative Colitis Immunology Drugs Product Introduction, Application and Specification
Table Pfizer Inc. Ulcerative Colitis Immunology Drugs Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Pfizer Inc. Ulcerative Colitis Immunology Drugs Production Growth Rate (2014-2019)
Table Pfizer Inc. Ulcerative Colitis Immunology Drugs Production Market Share (2014-2019)
Figure Pfizer Inc. Ulcerative Colitis Immunology Drugs Revenue Market Share (2014-2019)
Table Pfizer Inc. Ulcerative Colitis Immunology Drugs Main Business and Markets Served
Figure Global Ulcerative Colitis Immunology Drugs Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Ulcerative Colitis Immunology Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Ulcerative Colitis Immunology Drugs Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Ulcerative Colitis Immunology Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Ulcerative Colitis Immunology Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Ulcerative Colitis Immunology Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Ulcerative Colitis Immunology Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Ulcerative Colitis Immunology Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Ulcerative Colitis Immunology Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Ulcerative Colitis Immunology Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Ulcerative Colitis Immunology Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Ulcerative Colitis Immunology Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Ulcerative Colitis Immunology Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Ulcerative Colitis Immunology Drugs Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Ulcerative Colitis Immunology Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Ulcerative Colitis Immunology Drugs by Type (2019-2025)
Table Global Consumption (K Pcs) of Ulcerative Colitis Immunology Drugs by Application (2019-2025)
Table Ulcerative Colitis Immunology Drugs Distributors List
Table Ulcerative Colitis Immunology Drugs Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
潰瘍性大腸炎免疫薬のグローバル市場調査 2019年 The global Ulcerative Colitis Immunology Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Ulcerative Colitis Immunology Drugs volume and value at global level, regional level and company level.…- 腫瘍壊死因子(TNF)阻害薬のグローバル市場：規模・現状・予測2019-2025 A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …
- 腫瘍壊死因子(TNF)阻害薬のグローバル市場：規模・現状・予測2019-2025 A TNF inhibitor is a pharmaceutical drug that suppresses the physiologic response to tumor necrosis factor (TNF), which is part of the inflammatory response. TNF is involved in autoimmune and immune-mediated disorders such as rheumatoid arthritis, ankylosing spondylitis, inflammatory bowel disease, …
- 軸性脊椎関節炎薬のグローバル市場調査 2019年 The global Axial Spondyloarthritis Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Axial Spondyloarthritis Drugs volume and value at global level, regional level and company level. From a glob…
- エンティビオ（ベドリズマブ）薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn’s disease. Scope of the Report: This report focuses on the Entyvio (vedolizumab) Drug in global market, especially in North America, Europe and Asia-Pacific, South Amer…